No Data
Form 144 | Amneal Pharmaceuticals(AMRX.US) Director Proposes to Sell 261K in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Amneal Pharmaceuticals(AMRX.US)$ Director Autor Deborah M. intends to sell 38,000 shares of its common stock on May 16, with a total market value of approximately $261
Amneal Pharmaceuticals | 10-Q: Quarterly report
Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 Loss per Share (Vs US$0.046 Loss in 1Q 2023)
Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
4 analysts have expressed a variety of opinions on Amneal Pharmaceuticals (NASDAQ:AMRX) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below summarizes the
Amneal Pharmaceuticals Is Maintained at Buy by Goldman Sachs
Amneal Pharmaceuticals Is Maintained at Buy by Goldman Sachs
Express News | Goldman Sachs Maintains Buy on Amneal Pharmaceuticals, Raises Price Target to $8